Author: Daniel Mollenkamp
‘4/20’ celebration goes online as CBD marketing adapts to lockdown
Written by Daniel Mollenkamp || 20th April 2020 || Business briefing |
CBD companies have had to adapt marketing strategies as the COVID-19 pandemic has developed. The pandemic and the associated practice of social distancing have overtaken 4/20, the biggest promotional day for cannabis ...
US hemp crops going to rot and waste for lack of access to processing
Written by Daniel Mollenkamp || 25th November 2019 || Business briefing |
US hemp farmers are facing devastating crop rot due to a lack of processing capability and limited access to financial measures, according to an industry expert ...
Curaleaf in hot water with FDA over ‘improper health claims’
Written by Daniel Mollenkamp || 25th July 2019 || Regulatory briefing |
The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety ...
FDA gathers in opposing strong views and cannabis-related anecdotes
Written by Daniel Mollenkamp || 25th July 2019 || Business briefing |
The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views ...
Massachusetts upsets farmers by insisting on no CBD in food products
Written by Daniel Mollenkamp || 8th July 2019 || Regulatory briefing |
The Massachusetts Department of Agricultural Resources has confirmed that farmers and processors in the state cannot add CBD to food ingredients ...
USDA counsel says states cannot halt transport of legally-grown hemp
Written by Daniel Mollenkamp || 25th June 2019 || Regulatory briefing |
US states and tribal territories have no right to stop the transportation of legal hemp that conforms with US Department of Agriculture (USDA) guidelines or was produced under the terms of the 2014 Farm Bill ...
Poll finds very few Americans think they should be denied access to CBD
Written by Daniel Mollenkamp || 20th June 2019 || Business briefing |
Only 2% of Americans think CBD should not be available to consumers, according to a recent poll by the survey company Gallup ...
Banned or not? eBay appears to defy its own CBD prohibition
Written by Daniel Mollenkamp || 11th June 2019 || Business briefing |
Despite eBay’s claims to the contrary, CBD products appear to remain very much obtainable through the online marketplace. But are they the real thing? ...
Selected CBD businesses invited to test new payment and financial services
Written by Daniel Mollenkamp || 5th June 2019 || Business briefing |
Payments company Square is studying the potential for providing financial services to the CBD sector, with an invite-only beta test currently under way ...
Is the NFL about to relax its stance on CBD?
Written by Daniel Mollenkamp || 4th June 2019 || Business briefing |
CBD continues to gain ground across sports in North America; with recent visibility in sports like rugby and baseball, and no general proscription against CBD use from the World Anti-Doping Code, it may be making headway into American...
Bank associations pressure US Congress for cannabis banking reform
Written by Daniel Mollenkamp || 29th May 2019 || Regulatory briefing |
Banking associations from all across the US have written to the Senate to advocate for a hearing on cannabis banking reform ...
Martial arts company to help research use of CBD for athletes
Written by Daniel Mollenkamp || 24th May 2019 || Business briefing |
Aurora Cannabis is to collaborate with Ultimate Fighting Championship (UFC), a mixed martial arts promotions company headquartered in Las Vegas, on studies of CBD’s possible usefulness in treating pain and inflammation and in recovery and...
Judge’s ruling sets a precedent in patent law for cannabis extracts
Written by Daniel Mollenkamp || 24th May 2019 || Regulatory briefing |
Cannabinoid extracts require human intervention to change them from their natural state, a judge has ruled in a dispute that will help develop case law ...
US alcohol bureau won’t approve CBD-infused drinks – at least for now
Written by Daniel Mollenkamp || 20th May 2019 || Regulatory briefing |
The US Alcohol and Tobacco Tax and Trade Bureau (ATTB) has said it will not approve the use of "hemp-CBD" in alcohol products ...
Toronto Wolfpack becomes first sports team to field its own CBD product line
Written by Daniel Mollenkamp || 20th May 2019 || Business briefing |
A couple of Canadian companies are working with a professional rugby league team to bring cannabidiol products to athletes – and the general public ...
Tennessee brings ‘smoking hemp’ into its legal lexicon
Written by Daniel Mollenkamp || 17th May 2019 || Regulatory briefing |
The Tennessee legislature has enacted a bill which defines "smoking hemp" ...
It’s a chain reaction as US retailers join the rush to stock CBD products
Written by Daniel Mollenkamp || 15th May 2019 || Business briefing |
CBD has taken off in US retail, with a number of major chains – including some unexpected ones – taking opportunities to cash in on the surging popularity of CBD products ...
Legal CBD firms face cash chaos as US Bank cancels their card accounts
Written by Daniel Mollenkamp || 14th May 2019 || Business briefing |
Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal ...
US attorney general favours bid to let states decide cannabis and CBD policy
Written by Daniel Mollenkamp || 16th April 2019 || Regulatory briefing |
US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies ...
US Postal Service offers guidance on mail delivery of CBD products
Written by Daniel Mollenkamp || 4th April 2019 || Business briefing |
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the...
FDA wades in with guidance on CBD – and warnings over ‘deceptive’ claims
Written by Daniel Mollenkamp || 3rd April 2019 || Regulatory briefing |
A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims” ...
Mainstream US drugstore chains announce plans to sell CBD
Written by Daniel Mollenkamp || 29th March 2019 || Business briefing |
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has...
Canadian company Isodiol buys up California’s CBD Naturals
Written by Daniel Mollenkamp || 21st March 2019 || Business briefing |
Isodiol International, a large-scale CBD distributor based in Vancouver, Canada, has announced that it has acquired the brand and portfolio of California-based CBD Naturals ...
Takeovers and investments bloom as hemp takes root across North America
Written by Daniel Mollenkamp || 5th March 2019 || Business briefing |
North American companies such as Canadian firms Tilray and SOL Global, and Chicago-based Cresco Labs, are all starting or expanding their cannabidiol interests ...
State by state, US Farm Bill delivers different strokes for different folks
Written by Daniel Mollenkamp || 4th March 2019 || Regulatory briefing |
Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth ...
Confusion abounds in the tangle of US states’ CBD enforcement
Written by Daniel Mollenkamp || 26th February 2019 || Regulatory briefing |
Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers ...
Global CBD rules will get tougher, then normalise, expert predicts
Written by Daniel Mollenkamp || 20th February 2019 || Business briefing |
Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert ...
CBD company signs deal with mall giant to open branded stores across US
Written by Daniel Mollenkamp || 13th February 2019 || Business briefing |
Ohio-based CBD and cannabis company Green Growth Brands (GGB) is to open 108 retail locations in shopping malls across the US this year, including some of the most high-profile shopping locations in the country ...
US veterans urge CBD legalisation in Georgia, Tennessee drafts CBD bills
Written by Daniel Mollenkamp || 28th January 2019 || Regulatory briefing |
Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised ...
CBD to enter the big-time with coffee ads at the Super Bowl
Written by Daniel Mollenkamp || 28th January 2019 || Business briefing |
A series of advertisements for CBD products will be seen at Sunday’s Super Bowl LIII between the New England Patriots and the LA Rams, powerfully demonstrating their arrival in the US mainstream ...
Congress passes US Farm Bill with Hemp Farming Act intact
Written by Daniel Mollenkamp || 14th December 2018 || Regulatory briefing |
The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD industry ...
Charlotte’s Web can spread through drugstores, with help of Farm Bill
Written by Daniel Mollenkamp || 10th December 2018 || Business briefing |
Charlotte’s Web Holdings, which claims to be the market leader in “innovative hemp-based, CBD wellness products”, says it expects to add national drugstores to its thousands of locations in the US soon ...
US federal government soliciting information for CBD research
Written by Daniel Mollenkamp || 22nd November 2018 || Business briefing |
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute...
Exit Sessions – could the departure of the AG be good news for cannabis?
Written by Daniel Mollenkamp || 15th November 2018 || Regulatory briefing |
With the ousting of attorney general Jeff Sessions from the Trump administration, members of the US cannabis industry have perked up, hoping the anti-cannabis agenda will exit with him ...
Michigan says yes, North Dakota says no to recreational cannabis
Written by Daniel Mollenkamp || 7th November 2018 || Regulatory briefing |
Voters in Michigan have voted to legalise the recreational use of cannabis, while those in North Dakota rejected it. In Utah and Missouri medical cannabis use was approved on the day the US turned out to vote in...
CBD.io teams up with vape expo for major Las Vegas show
Written by Daniel Mollenkamp || 17th October 2018 || Business briefing |
A major CBD show is to be held in Las Vegas next month in what is billed as “an epic collaboration of two industries”. The CBD.io event will take place on 9th and 10th November in conjunction with...
Hemp still on federal narcotics list as Congressional deadline lapses
Written by Daniel Mollenkamp || 8th October 2018 || Regulatory briefing |
A deadline for the federal legislature to pass a bill expected to remove hemp and low-THC cannabis from the federal list of narcotics lapsed on 30th September, leaving US hemp farmers in regulatory uncertainty ...
Massachusetts growers losing patience over licensing hold-ups
Written by Daniel Mollenkamp || 18th September 2018 || Business briefing |
Cannabis growers in Massachusetts have indicated they may sue the state’s Cannabis Control Commission over a dispute that appears to have delayed the start of legal sales there ...
‘Cannabis with nicotine affects brain differently than either on its own’
Written by Daniel Mollenkamp || 11th September 2018 || Business briefing |
Cannabis and nicotine together have notably different effects on the brain than either of them taken on their own. That’s the conclusion of US researchers who noted that cannabis is commonly consumed in conjunction with tobacco ...
Potentially deadly rat poison found in synthetic cannabinoids, says FDA
Written by Daniel Mollenkamp || 30th July 2018 || Regulatory briefing |
Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says ...
If FDA approves CBD drug it could be a game-changer for the vapour industry
Written by Daniel Mollenkamp || 31st May 2018 || Regulatory briefing |
The first ever FDA-approved cannabis-derived product came a step nearer reality when an independent panel at the agency recommended it as a “safe” and “efficacious” treatment for childhood seizures ...
Is PMI preparing for a future move into the cannabis business?
Written by Daniel Mollenkamp || 13th March 2018 || Business briefing |
In our latest report on developments in the legal cannabis market, CBD-Intel considers whether PMI may be setting up a future move in that direction. We also look at the potential dangers of synthetic cannabis products ...